Last week’s round-up, 18-22 November 2019

By Stephanie Allampalli and Marthese Mifsud CHMP’s Position on NDMA in Ranitidine 21 November 2019 The CHMP has held discussions on the course of action to be taken within the EU over the presence of the carcinogenic impurity NDMA in some batches of ranitidine medicines. In order to assess the potential root causes and their […]

Read More

Last week’s round-up, 04 – 08 November 2019

By Tessa Fiorini-Cohen and Marthese Mifsud   IPEC Continues to Encourage China to Align with Global Science-Based Excipient Standards 08 November 2019 Global excipient manufacturers are continuing to push the Chinese Pharmacopoeia to align with other pharmacopoeias. Manufacturers are working through the International Pharmaceutical Excipients Council (IPEC), which is closely monitoring changes to requirements for […]

Read More